» Articles » PMID: 15557632

A Mutant of Mycobacterium Tuberculosis H37Rv That Lacks Expression of Antigen 85A is Attenuated in Mice but Retains Vaccinogenic Potential

Overview
Journal Infect Immun
Date 2004 Nov 24
PMID 15557632
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The fbpA and fbpB genes encoding the 85A and 85B proteins of Mycobacterium tuberculosis H37Rv, respectively, were disrupted, the mutants were examined for their ability to survive, and the strain lacking 85A (DeltafbpA) was tested for its ability to immunize mice. The DeltafbpA mutant was attenuated in mice after intravenous or aerosol infection, while replication of the DeltafbpB mutant was similar to that of the wild type. Complementation of the fbpA gene in DeltafbpA restored its ability to grow in the lungs of mice. The DeltafbpA mutant induced a stronger expression of pulmonary mRNA messages in mice for tumor necrosis factor alpha, interleukin-1 beta (IL-1beta), gamma interferon, IL-6, IL-2, and inducible nitric oxide (NO) synthase, which led to its decline, while H37Rv persisted despite strong immune responses. H37Rv and DeltafbpA both induced NO in macrophages and were equally susceptible to NO donors, although DeltafbpA was more susceptible in vitro to peroxynitrite and its growth was enhanced by NO inhibitors in mice and macrophages. Aerosol-infected mice, which cleared a low-dose DeltafbpA infection, resisted a challenge with virulent M. tuberculosis. Mice subcutaneously immunized with DeltafbpA or Mycobacterium bovis BCG and challenged with M. tuberculosis also showed similar levels of protection, marked by a reduction in the growth of challenged M. tuberculosis. The DeltafbpA mutant was thus attenuated, unlike DeltafbpB, but was also vaccinogenic against tuberculosis. Attenuation was incomplete, however, since DeltafbpA revived in normal mice after 370 days, suggesting that revival was due to immunosenescence but not compensation by the fbpB or fbpC gene. Antigen 85A thus affects susceptibility to peroxynitrite in M. tuberculosis and appears to be necessary for its optimal growth in mice.

Citing Articles

The candidate vaccine derived from H37Rv is markedly immunogenic in macrophages and induces robust immunity to tuberculosis in mice.

Mishra A, Khan A, Singh V, Glyde E, Saikolappan S, Garnica O Front Immunol. 2024; 15:1321657.

PMID: 38975346 PMC: 11224292. DOI: 10.3389/fimmu.2024.1321657.


Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria.

Veerapandian R, Gadad S, Jagannath C, Dhandayuthapani S Vaccines (Basel). 2024; 12(5).

PMID: 38793781 PMC: 11126151. DOI: 10.3390/vaccines12050530.


A novel mutation alters the stability of PapA2 resulting in the complete abrogation of sulfolipids in clinical mycobacterial strains.

Panchal V, Jatana N, Malik A, Taneja B, Pal R, Bhatt A FASEB Bioadv. 2020; 1(5):306-319.

PMID: 32123834 PMC: 6996325. DOI: 10.1096/fba.2018-00039.


Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Nguyen T, dAigle J, Chinea L, Niaz Z, Hunter R, Hwang S Am J Pathol. 2019; 190(2):286-294.

PMID: 31734231 PMC: 7013273. DOI: 10.1016/j.ajpath.2019.10.006.


An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.

Khan A, Bakhru P, Saikolappan S, Das K, Soudani E, Singh C NPJ Vaccines. 2019; 4:34.

PMID: 31396406 PMC: 6683161. DOI: 10.1038/s41541-019-0122-8.


References
1.
Russo D, Kozlova N, Lakey D, Kernodle D . Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins. Infect Immun. 2000; 68(12):6826-32. PMC: 97786. DOI: 10.1128/IAI.68.12.6826-6832.2000. View

2.
Kaushal D, Schroeder B, Tyagi S, Yoshimatsu T, Scott C, Ko C . Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci U S A. 2002; 99(12):8330-5. PMC: 123067. DOI: 10.1073/pnas.102055799. View

3.
Springer B, Master S, Sander P, Zahrt T, McFalone M, Song J . Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect Immun. 2001; 69(10):5967-73. PMC: 98723. DOI: 10.1128/IAI.69.10.5967-5973.2001. View

4.
Actor J, Breij E, Wetsel R, Hoffmann H, Hunter Jr R, Jagannath C . A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scand J Immunol. 2001; 53(5):464-74. DOI: 10.1046/j.1365-3083.2001.00902.x. View

5.
Stewart G, Ehrt S, Riley L, Dale J, McFadden J . Deletion of the putative antioxidant noxR1 does not alter the virulence of Mycobacterium tuberculosis H37Rv. Tuber Lung Dis. 2000; 80(4-5):237-42. DOI: 10.1054/tuld.2000.0251. View